BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 18171268)

  • 1. Tight regulation of the Epstein-Barr virus setpoint: interindividual differences in Epstein-Barr virus DNA load are conserved after HIV infection.
    Piriou E; van Dort K; Otto S; van Oers MH; van Baarle D
    Clin Infect Dis; 2008 Jan; 46(2):313-6. PubMed ID: 18171268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
    AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients.
    Petrara MR; Cattelan AM; Zanchetta M; Sasset L; Freguja R; Gianesin K; Cecchetto MG; Carmona F; De Rossi A
    J Clin Virol; 2012 Mar; 53(3):195-200. PubMed ID: 22209290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute level of Epstein-Barr virus DNA in human immunodeficiency virus type 1 infection is not predictive of AIDS-related non-Hodgkin lymphoma.
    Van Baarle D; Wolthers KC; Hovenkamp E; Niesters HG; Osterhaus AD; Miedema F; Van Oers MH
    J Infect Dis; 2002 Aug; 186(3):405-9. PubMed ID: 12134237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH; Wolf H; Minarovits J
    Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of Epstein-Barr virus detected in the cerebrospinal fluid of people with HIV infection.
    Wang J; Ozzard A; Nathan M; Atkins M; Nelson M; Gazzard B; Bower M
    HIV Med; 2007 Jul; 8(5):306-11. PubMed ID: 17561877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-Epstein-Barr virus relationship affected by immunostimulation in HIV-infected patients representing distinct progressor profile groups.
    Friis AM; Åkerlund B; Gyllensten K; Aleman A; Ernberg I
    Scand J Infect Dis; 2012 May; 44(5):388-92. PubMed ID: 22243136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A longitudinal and prospective study of Epstein-Barr virus load in AIDS-related non-Hodgkin lymphoma.
    Bonnet F; Jouvencel AC; Parrens M; Leon MJ; Cotto E; Garrigue I; Morlat P; Beylot J; Fleury H; Lafon ME
    J Clin Virol; 2006 Aug; 36(4):258-63. PubMed ID: 16762591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection.
    Friis AM; Akerlund B; Gyllensten K; Aleman A; Bratt G; Sandström E; Ernberg I
    Vaccine; 2012 Sep; 30(42):6093-8. PubMed ID: 22863659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential dynamics of Epstein-Barr virus in individuals infected with human immunodeficiency virus-1 receiving intermittent interleukin-2 and antiretroviral therapy.
    Burighel N; Ghezzi S; Nozza S; Del Bianco P; Lazzarin A; Tambussi G; Poli G; De Rossi A
    Haematologica; 2006 Feb; 91(2):244-7. PubMed ID: 16461311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood.
    Bakker NA; Verschuuren EA; Veeger NJ; van der Bij W; van Imhoff GW; Kallenberg CG; Hepkema BG
    J Heart Lung Transplant; 2008 Jan; 27(1):7-10. PubMed ID: 18187080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Close relationship between immunoglobulin secreting-cells and Epstein-Barr virus reservoir in patients infected with HIV.
    Ouedraogo DE; Tuaillon E; Rubbo PA; Bollore K; Foulongne V; Reynes J; Vendrell JP
    J Med Virol; 2014 Jan; 86(1):30-7. PubMed ID: 24114930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virological responses in a patient with recent HIV-1 infection experiencing an EBV reactivation.
    Tassan Din C; Vecchi A; Tambussi G; De Rossi A; Bestetti A; Biswas P
    New Microbiol; 2007 Jul; 30(3):283-5. PubMed ID: 17802910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Epstein-Barr virus (EBV) viral load can be a complementary sensitive test in primary Epstein-Barr virus infection.
    Berth M; Vanheule G; Depuydt C; Benoy I
    J Clin Virol; 2011 Feb; 50(2):184-5. PubMed ID: 21112811
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequent detection of Epstein-Barr Virus and cytomegalovirus but not JC virus DNA in cerebrospinal fluid samples from human immunodeficiency virus-infected patients in northern Thailand.
    Rojanawiwat A; Miura T; Thaisri H; Pathipvanich P; Umnajsirisuk S; Koibuchi T; Vongsheree S; Iwamoto A; Ariyoshi K; Sawanpanyalert P
    J Clin Microbiol; 2005 Jul; 43(7):3484-6. PubMed ID: 16000485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B lymphocytes and Epstein-Barr virus: the lesson of post-transplant lymphoproliferative disorders.
    Dolcetti R
    Autoimmun Rev; 2007 Dec; 7(2):96-101. PubMed ID: 18035317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus.
    Giron LB; Ramos da Silva S; Barbosa AN; Monteiro de Barros Almeida RA; Rosário de Souza Ld; Elgui de Oliveira D
    J Med Virol; 2013 Dec; 85(12):2110-8. PubMed ID: 24014234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.